Translating the ABC-02 trial into daily practice: outcome of palliative treatmen
- This topic has 0 replies, 1 voice, and was last updated 6 years, 4 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Translating the ABC-02 trial into daily practice: outcome of palliative treatment in patients with unresectable biliary tract cancer treated with gemcitabine and cisplatin.
“CONCLUSION:
First-line gemcitabine and cisplatin is an effective and safe treatment for patients with unresectable BTC who do not meet the eligibility criteria for the ABC-02 trial. Median OS, PFS and treatment side effects were comparable between the patients who received chemotherapy (group I vs. group II).”https://www.ncbi.nlm.nih.gov/pubmed/29265948
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.